Deciphering the role of signal regulatory protein α in immunotherapy for solid tumors
Therapies targeting immune checkpoints like programmed death receptor-1 and programmed death ligand-1 have demonstrated remarkable effectiveness in combating cancer. However, a subset of patients fails to respond to these therapies, underscoring the complexity of tumor immune evasion mechanisms. Exp...
Saved in:
| Main Authors: | Yulong Zhou, Xiyang Tang, Weiguang Du, Chen Shu, Xiaolong Yan, Nan Ma, Jinbo Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1612234/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy
by: Anna Reischer, et al.
Published: (2025-05-01) -
Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathway
by: Zubair Hussain, et al.
Published: (2025-06-01) -
Blocking the SIRPα-CD47 axis promotes macrophage phagocytosis of exosomes derived from visceral adipose tissue and improves inflammation and metabolism in mice
by: Yun-kai Lin, et al.
Published: (2025-02-01) -
CDH17-targeting CAR-NK cells synergize with CD47 blockade for potent suppression of gastrointestinal cancers
by: Liuhai Zheng, et al.
Published: (2025-05-01) -
Concurrent immune checkpoint blockade for enhanced cancer immunotherapy utilizing engineered hybrid nanovesicles
by: Yuxuan Liu, et al.
Published: (2024-11-01)